Marinomed wins STEP award in "Market/Customer" category and special award for strategic partnerships
Marinomed Biotechnologie GmbH announced that it has won the €10,000-endowed Step Award 2010 in the "Market/ Customer” category. Marinomed also received an award in the amount of €5,000 for its strategic cooperation with the company, Boehringer Ingelheim Pharma. The special strategic partnership prize was donated by TVM. This is the fifth year in which the STEP Award has been presented to innovative, high growth companies in the chemical, pharmaceutical, life science, bio-/nanotechnology, medical technology and green technology industries from Germany, Austria and Switzerland.
Marinomed impressed the jury in the "Market/ Customer" category, as its anti-viral nasal spray features significant and direct benefits for the patient, the end consumer. In addition, the strategic cooperation agreement out-licensing the nasal spray to Boehringer Ingelheim for the European, Latin American, Russian & CIS, Asian and Australian markets clearly shows the product’s high market potential.
Dr. Andreas Grassauer, CEO and co-founder of Marinomed, commented: “We are delighted that Marinomed has been awarded with these two prizes. They not only confirm our successful business strategy, but also the value of our innovative product.”
Other news from the department business & finance
